Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period.
Hiba DagherAnne-Marie ChaftariIshwaria M SubbiahAlexandre E MalekYing JiangPeter LamieBruno GranwehrTeny JohnEduardo YepezJovan BorjanCielito C Reyes-GibbyMary FloresFareed KhawajaMala PandeNoman AliRaniv RojoDaniel D KarpPatrick ChaftariRay HachemIssam I RaadPublished in: eLife (2023)
This research is supported by the National Institutes of Health/National Cancer Institute under award number P30CA016672, which supports the MD Anderson Cancer Center Clinical Trials Office. The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.
Keyphrases
- clinical trial
- end stage renal disease
- coronavirus disease
- healthcare
- sars cov
- chronic kidney disease
- ejection fraction
- newly diagnosed
- mental health
- papillary thyroid
- prognostic factors
- electronic health record
- big data
- molecular dynamics
- machine learning
- young adults
- artificial intelligence
- deep learning
- protein kinase